Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen
- 1 January 2003
- journal article
- research article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 34 (1) , 39-45
- https://doi.org/10.1016/s0882-4010(02)00194-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Structural analysis of Francisella tularensis lipopolysaccharideEuropean Journal of Biochemistry, 2002
- Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVSMicrobial Pathogenesis, 2002
- Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensisVaccine, 2001
- Purified Lipopolysaccharide fromFrancisella tularensisLive Vaccine Strain (LVS) Induces Protective Immunity against LVS Infection That Requires B Cells and Gamma InterferonInfection and Immunity, 2000
- Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organismFEMS Immunology & Medical Microbiology, 1996
- Immunogenicity and toxicity of lipopolysaccharide fromFrancisella tularensisLVSFEMS Microbiology Letters, 1992
- Structure of the O-antigen of Francisella tularensis strain 15Carbohydrate Research, 1991
- Structure of the D-glucans produced by Neisseria perflavaCanadian Journal of Microbiology, 1978
- Improved techniques for the preparation of bacterial lipopolysaccharidesCanadian Journal of Microbiology, 1975
- Tularemia Vaccine StudyArchives of internal medicine (1960), 1961